Introducing ADI’s new CEO: Dr. Faith Mwangi-Powell
ADI announces our new CEO, joining on 1 October 2026
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
ADI announces our new CEO, joining on 1 October 2026
In this guest article, ADI Board Member and dementia advocate, Bill Yeates, shares his post diagnosis journey, discussing the hopes and challenges of life between scans.
In this blog, the co-leaders of the Brain Health Diplomacy Working Group from The Global Brain Health Institute (GBHI), write about the necessity for brain health diplomacy in advancing better brain health.
Raymond Xiong writes about his inspiration behind creating and sharing MECA exercises, which incorporate music, gymnastics and cognitive activity, to improve the wellbeing of people living with dementia.
The annual Alzheimer University (AU) assists emerging Alzheimer and dementia associations.
World Alzheimers Month 2021 has just ended and marks the most successful awareness raising campaign to date in its decade long history.
Eisai’s lecanemab will represent the second anti-Amyloid Beta therapy to be evaluated by the FDA as a disease modifying treatment for early Alzheimer’s disease.
This is the press release for the World Alzheimer Report 2021 'Journey through the diagnosis of dementia'
This report reviews progress towards the implementation of the 7 action areas of the plan by Member States, WHO and civil society, and all those involved in tackling the dementia pandemic.
People living with dementia and carers from all over the world have shared their experience of the journey to diagnosis for this year's World Alzheimer's Month campaign.